/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

← → days · ↑ ↓ browse · Enter similar · o open

Vetster, a marketplace and telehealth startup for pet care, raises a $30M Series B led by Kensington, and partners with online pet medications company PetMeds

Joan Verdon / Forbes :

Forbes Joan Verdon

Context & Ripple Effects

Vet telehealth has been a steady fundraising lane since FirstVet's 2019 on-demand video consultation round, followed by Airvet and then Modern Animal's $40M bet on 24/7 telemedicine and a reworked labor model for veterinarians. What has been missing from most of these models is a direct path to the prescription dollars that follow a consultation.

Vetster's $30M Series B led by Kensington closes that loop: alongside the raise it partners with PetMeds, an established online pet pharmacy, so consultations can convert into medication sales rather than referrals out of the platform.

First-order effects

  • Vetster now has both the capital and the distribution to run a consult-to-prescription funnel through PetMeds, monetizing each video visit twice instead of handing the pharmacy revenue to third parties.
  • The partnership puts Vetster in direct overlap with Mixlab's veterinarian-prescribed medication delivery model, which raised its own round for exactly this attach-rate logic.

Second-order effects

  • Rival marketplaces like FirstVet and Airvet face pressure to bolt on their own pharmacy partnerships or commerce layer, since a competitor that captures post-consult drug spend can subsidize cheaper or free consultations.
  • Clinic-side software players such as Otto are pushed toward integration deals with pharmacies too, as the line between practice management tools and consumer-facing consult-and-med platforms blurs.

Third-order effects

  • If the pattern holds, veterinary telehealth consolidates into two structures — consumer marketplaces that own the consult-plus-pharmacy bundle, and clinic infrastructure vendors — with standalone video-consult apps squeezed between them.
  • Pharmacy attachment becomes the unit-economics battleground that decides which telehealth players survive their next raise, echoing how Modern Animal tied its model to restructuring veterinarian labor economics.

The trend: Veterinary telehealth is evolving from standalone video consultations into consult-plus-pharmacy platforms, with medication attach rates becoming the metric that separates fundable models from commoditized ones.